Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP served as legal counsel to Hims & Hers, while Kirkland & Ellis LLP served as legal counsel to Oaktree Acquisition Corp. in the transaction.
Oaktree Acquisition Corp. (NYSE: OAC.U, OAC, OAC WS), a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management, L.P. (“Oaktree”), comopleted its business combination with Hims, Inc. (“Hims & Hers”), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high quality medical care for numerous conditions.
The combined company is expected to have an initial market capitalization of approximately $1.6 billion. Upon completion of the transaction, the combined company’s securities are expected to be traded on the New York Stock Exchange (NYSE) under the symbol “HIMS.” The transaction is expected to close in the fourth quarter of 2020.
LionTree Advisors served as exclusive financial advisor to Hims & Hers. Credit Suisse and Deutsche Bank Securities served as capital markets advisors and private placement agents to Oaktree Acquisition Corp. Deutsche Bank Securities acted as financial advisor to Oaktree Acquisition Corp.
The Kirkland team advising Oaktree was led by transactional partners Matthew Arenson (Picture) and Nathan Davis and capital markets partners Christian Nagler and Peter Seligson, and also included transactional partner Hamed Meshki, capital markets partner Bradley Reed, healthcare partners Dennis Williams and Chad Ehrenkranz, and tax partner Michael Beinus.
Involved fees earner: Matthew Arenson – Kirkland & Ellis; Michael Beinus – Kirkland & Ellis; Nathan Davis – Kirkland & Ellis; Chad Ehrenkranz – Kirkland & Ellis; Hamed Meshki – Kirkland & Ellis; Christian Nagler – Kirkland & Ellis; Bradley Reed – Kirkland & Ellis; Peter Seligson – Kirkland & Ellis; Dennis Williams – Kirkland & Ellis;
Law Firms: Kirkland & Ellis;
Clients: Oaktree Acquisition Corp.;